menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Statin Safety Considerations

close
Statin Safety Considerations
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Recently, the FDA released data that claimed some the adverse events of statin therapy may lead to diabetes. But, how great are those adverse events? Should physicians and their patients have great concern? Listen in as Dr. Alan Brown welcomes Dean Bramlett, MD as they discuss statin safety, statin toxicity and the overall effectiveness of statins. Dr. Bramlett is the medical director of the Heart and Lipid Institute of Florida in St. Petersburg, Florida; and, assistant consultant professor at Duke University.

    Brought to you by:

    NLA logo

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Recently, the FDA released data that claimed some the adverse events of statin therapy may lead to diabetes. But, how great are those adverse events? Should physicians and their patients have great concern? Listen in as Dr. Alan Brown welcomes Dean Bramlett, MD as they discuss statin safety, statin toxicity and the overall effectiveness of statins. Dr. Bramlett is the medical director of the Heart and Lipid Institute of Florida in St. Petersburg, Florida; and, assistant consultant professor at Duke University.

    Brought to you by:

    NLA logo

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/24/20